Diabetes Care Devices Market Projected to Grow 7.26% Annually Through 2034

DelveInsight Analysis Forecasts Robust Expansion in Diabetes Monitoring and Management Devices

Mar. 18, 2026 at 1:34am

Got story updates? Submit your updates here. ›

According to a new report by DelveInsight, the global diabetes care devices market is expected to grow from $40.8 billion in 2025 to $76.4 billion by 2034, driven by the rising prevalence of diabetes, increased adoption of advanced technologies like continuous glucose monitoring (CGM) systems and insulin pumps, and greater awareness around early diagnosis and effective disease management.

Why it matters

The expanding diabetes care devices market reflects the growing global burden of the disease, fueled by factors like obesity, sedentary lifestyles, and an aging population. As the number of diabetes cases rises, the demand for innovative solutions to monitor and manage blood glucose levels is increasing, underscoring the importance of these devices in improving disease control and preventing complications.

The details

The diabetes care devices market features a competitive landscape with both established global players and emerging technology innovators. Key market drivers include the increasing prevalence of diabetes, greater adoption of advanced devices like CGMs and smart insulin pens, and rising awareness around early detection and continuous monitoring. North America is expected to hold the largest market share, driven by high diabetes incidence, robust healthcare infrastructure, supportive reimbursement policies, and the strong presence of major industry players.

  • The global diabetes care devices market size is projected to grow from $40.8 billion in 2025 to $76.4 billion by 2034.
  • During the 2026-2034 forecast period, the market is anticipated to register a compound annual growth rate (CAGR) of 7.26%.

The players

Becton, Dickinson and Company

A leading global medical technology company that manufactures and sells medical devices, instrument systems, and reagents.

Novo Nordisk A/S

A Danish multinational pharmaceutical company that specializes in diabetes care and other serious chronic conditions.

Medtronic plc

A global leader in healthcare technology, providing innovative solutions for diabetes management, including continuous glucose monitors and insulin pumps.

Dexcom Inc.

A medical device company that develops and manufactures continuous glucose monitoring (CGM) systems for people with diabetes.

Abbott

A global healthcare company that develops a range of diabetes care devices, including glucose monitoring systems and insulin delivery products.

Got photos? Submit your photos here. ›

What’s next

As the diabetes care devices market continues to evolve, industry leaders and healthcare professionals will closely monitor the introduction of new technologies, regulatory approvals, and market trends to stay ahead of the curve and provide the best possible care for individuals with diabetes.

The takeaway

The rapid growth of the diabetes care devices market underscores the critical role these innovative solutions play in improving disease management and patient outcomes. As the global prevalence of diabetes rises, the demand for advanced monitoring and delivery systems will only continue to increase, driving further advancements in this dynamic and rapidly expanding sector of the healthcare industry.